Újdonságok a gyermekkori immunthrombocytopenia kezelésében - 2017

Translated title of the contribution: Novelties in the treatment of pediatric immune thrombocytopenia - 2017

Kovács Gábor, C. Kiss

Research output: Contribution to journalReview article

Abstract

Immune thrombocitopenia in children is a very variable disease. International recommendations give therapeutic possibilities without strong protocols. In 2011, a therapeutic algorithm was published based on Hungarian practice. Recently, new innovative drugs have been available even in Hungary, so there is a need for modification of the therapeutic protocols. In this summary we give an overview about the current up-to-date management. In infancy and in childhood, high-dose immunglobulin treatment is recommended henceforward. In older children an alternative can be steroid therapy (pulses or long-term low-dose treatment). In resistant cases, a new thrombopoetin receptor stimulant, eltrombopag can be administered. This drug is registered in Hungary, and can very effectively influence the prognosis. Splenectomy is very rare nowadays in children. Immune thrombocytopenia is an unpredictable disease. Cure rate is about 70-80% of the cases, but management of the patients needs special care and specialist.

Original languageHungarian
Pages (from-to)1891-1896
Number of pages6
JournalOrvosi Hetilap
Volume158
Issue number48
DOIs
Publication statusPublished - Dec 1 2017

Fingerprint

Idiopathic Thrombocytopenic Purpura
Pediatrics
Hungary
Therapeutics
Case Management
Splenectomy
Pharmaceutical Preparations
Steroids

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Újdonságok a gyermekkori immunthrombocytopenia kezelésében - 2017. / Gábor, Kovács; Kiss, C.

In: Orvosi Hetilap, Vol. 158, No. 48, 01.12.2017, p. 1891-1896.

Research output: Contribution to journalReview article

Gábor, Kovács ; Kiss, C. / Újdonságok a gyermekkori immunthrombocytopenia kezelésében - 2017. In: Orvosi Hetilap. 2017 ; Vol. 158, No. 48. pp. 1891-1896.
@article{208f98dfb33b484da9bd9e5f725544b6,
title = "{\'U}jdons{\'a}gok a gyermekkori immunthrombocytopenia kezel{\'e}s{\'e}ben - 2017",
abstract = "Immune thrombocitopenia in children is a very variable disease. International recommendations give therapeutic possibilities without strong protocols. In 2011, a therapeutic algorithm was published based on Hungarian practice. Recently, new innovative drugs have been available even in Hungary, so there is a need for modification of the therapeutic protocols. In this summary we give an overview about the current up-to-date management. In infancy and in childhood, high-dose immunglobulin treatment is recommended henceforward. In older children an alternative can be steroid therapy (pulses or long-term low-dose treatment). In resistant cases, a new thrombopoetin receptor stimulant, eltrombopag can be administered. This drug is registered in Hungary, and can very effectively influence the prognosis. Splenectomy is very rare nowadays in children. Immune thrombocytopenia is an unpredictable disease. Cure rate is about 70-80{\%} of the cases, but management of the patients needs special care and specialist.",
keywords = "Bleeding, Immunglobulin, Pediatric ITP, Therapeutic recommendation, Thrombopoetin receptor stimulant",
author = "Kov{\'a}cs G{\'a}bor and C. Kiss",
year = "2017",
month = "12",
day = "1",
doi = "10.1556/650.2017.30934",
language = "Hungarian",
volume = "158",
pages = "1891--1896",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "48",

}

TY - JOUR

T1 - Újdonságok a gyermekkori immunthrombocytopenia kezelésében - 2017

AU - Gábor, Kovács

AU - Kiss, C.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Immune thrombocitopenia in children is a very variable disease. International recommendations give therapeutic possibilities without strong protocols. In 2011, a therapeutic algorithm was published based on Hungarian practice. Recently, new innovative drugs have been available even in Hungary, so there is a need for modification of the therapeutic protocols. In this summary we give an overview about the current up-to-date management. In infancy and in childhood, high-dose immunglobulin treatment is recommended henceforward. In older children an alternative can be steroid therapy (pulses or long-term low-dose treatment). In resistant cases, a new thrombopoetin receptor stimulant, eltrombopag can be administered. This drug is registered in Hungary, and can very effectively influence the prognosis. Splenectomy is very rare nowadays in children. Immune thrombocytopenia is an unpredictable disease. Cure rate is about 70-80% of the cases, but management of the patients needs special care and specialist.

AB - Immune thrombocitopenia in children is a very variable disease. International recommendations give therapeutic possibilities without strong protocols. In 2011, a therapeutic algorithm was published based on Hungarian practice. Recently, new innovative drugs have been available even in Hungary, so there is a need for modification of the therapeutic protocols. In this summary we give an overview about the current up-to-date management. In infancy and in childhood, high-dose immunglobulin treatment is recommended henceforward. In older children an alternative can be steroid therapy (pulses or long-term low-dose treatment). In resistant cases, a new thrombopoetin receptor stimulant, eltrombopag can be administered. This drug is registered in Hungary, and can very effectively influence the prognosis. Splenectomy is very rare nowadays in children. Immune thrombocytopenia is an unpredictable disease. Cure rate is about 70-80% of the cases, but management of the patients needs special care and specialist.

KW - Bleeding

KW - Immunglobulin

KW - Pediatric ITP

KW - Therapeutic recommendation

KW - Thrombopoetin receptor stimulant

UR - http://www.scopus.com/inward/record.url?scp=85037124668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037124668&partnerID=8YFLogxK

U2 - 10.1556/650.2017.30934

DO - 10.1556/650.2017.30934

M3 - Review article

C2 - 29172661

AN - SCOPUS:85037124668

VL - 158

SP - 1891

EP - 1896

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 48

ER -